Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Health Impact of Cystic Fibrosis in the United States
An estimated 30,000 people in the United States have cystic fibrosis (CF). Approximately 1000 children each year are born with the disease, which is one of the most common childhood onset genetic diseases that shortens the lives of affected individuals. Important treatment advances have combined to promote survival of patients with CF well into adulthood. A 2006 report from the Cystic Fibrosis Foundation registry gave the median age of survival at that time as 37 years.
Keywords: cystic fibrosis | health impact | incidence | genetic disease | childhood | CF | rhGH | recombinant human growth hormone | human growth hormone | HGH
- Centers for Disease Control and Prevention. Newborn screening of cystic fibrosis, morbidity and mortality weekly report 2004; 353 (RR13):1-36.
- Cystic Fibrosis Foundation, Patient Registry 2006 Annual Report. 2006.
- Centers for Disease Control and Prevention. National offices of public health genomics. Cystic fibrosis clinical validity 2007.
Your slide tray is being processed.